Last reviewed · How we verify
Gabapentin dispensed to subject. — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Gabapentin dispensed to subject. (Gabapentin dispensed to subject.) — Dr. Kirk Brower.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Gabapentin dispensed to subject. TARGET | Gabapentin dispensed to subject. | Dr. Kirk Brower | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Gabapentin dispensed to subject. CI watch — RSS
- Gabapentin dispensed to subject. CI watch — Atom
- Gabapentin dispensed to subject. CI watch — JSON
- Gabapentin dispensed to subject. alone — RSS
Cite this brief
Drug Landscape (2026). Gabapentin dispensed to subject. — Competitive Intelligence Brief. https://druglandscape.com/ci/gabapentin-dispensed-to-subject. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab